Rezon Bio published an article by COO Ralf Otto discussing product-oriented ownership and cultural fit in biologics CDMO selection.
Public source
Publisher name
Public post
Selecting the right biologics CDMO is not only about price competitiveness, high quality standards and technological fit. It is also a matter of Product-Oriented Ownersh…
Company
Rezon Bio
Where Dedication Delivers Biologics
- Industry
- Biotechnology Research
- Location
- Gdansk, PL
- Company size
- 501–1,000 employees
About Rezon Bio
Rezon Bio is a science-driven contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian biologics. Headquartered in Poland, Rezon Bio offers integrated solutions spanning cell line development, commercial drug substance manufacturing, and drug product development. The company operates with state-of-the-art facilities, world-class teams, and a proven track record of regulatory and commercial success. Drawing on a legacy of biosimilars development and global commercialization, Rezon Bio combines experience, digital transparency, and cost-to-value efficiency to help clients move from concept to market with confidence.
See moreLatest activity
Latest activity from Rezon Bio
9 signals
Presence & Recognition
Rezon Bio is attending Nordic Life Science Days 2026 in Stockholm, booth E:01, to connect with biotech and biopharma companies, exchange insights, and explore collaboration opportunities across biologics development and manufacturing.
Customers & Market
Rezon Bio is offering in the Biologics CDMO space with BD team members and Marketing & Communication team members attending a presentation.
Presence & Recognition
Rezon Bio is hosting the BioPhorum Drug Substance, BioPhorum Quality and BioPhorum Sustainability communities for three days from 29 September to 1 October in Warsaw.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
53Biologics
53Biologics published an article exploring questions that help distinguish a capable service provider from a CDMO prepared to take ownership and keep the program moving when the stakes increase.
Research & Knowledge
Ensorcell
Ensorcell published an article exploring how facility and equipment design, cleaning validation, single-use technologies, closed processing, and sterile fluid transfer work together to reduce cross-contamination risk while maintaining bioprocessing flexibility.
Research & Knowledge
Rapid Micro Biosystems
Rapid Micro Biosystems published a whitepaper exploring how microbial quality control can become a strategic advantage for CDMOs.
Research & Knowledge
Afton Scientific, LLC
Afton Scientific, LLC published an article examining how CDMOs help sponsors navigate supply chain control, traceability, and regulatory compliance from sourcing through delivery.
Research & Knowledge
CDMO Advisor ™